<!doctype html><html lang=en-us>
<head>
<meta charset=utf-8>
<meta name=viewport content="width=device-width,initial-scale=1">
<meta http-equiv=x-ua-compatible content="IE=edge">
<meta name=generator content="Wowchemy 5.4.0 for Hugo">
<link rel=preconnect href=https://fonts.gstatic.com crossorigin>
<link rel=preload as=style href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;700&family=Roboto+Mono&family=Roboto:wght@400;700&display=swap">
<link rel=stylesheet href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;700&family=Roboto+Mono&family=Roboto:wght@400;700&display=swap" media=print onload="this.media='all'">
<meta name=author content="Geert Litjens">
<meta name=description content="Melanoma associated antigens (MAGE) are potential targets for immunotherapy and have been associated with poor overall survival (OS) in head and neck squamous cell carcinoma (HNSCC). However, little is known about MAGE in lymph node metastases (LNM) and recurrent disease (RD) of HNSCC.To assess whether MAGE expression increases with metastasis or recurrence, a tissue microarray (TMA) of 552 primary tumors (PT), 219 LNM and 75 RD was evaluated by immunohistochemistry for MAGE antigens using three monoclonal antibodies to multiple MAGE family members. Mean expression intensity (MEI) was obtained from triplicates of each tumor specimen.The median MEI compared between PT, LNM and RD was significantly higher in LNM and RD. In paired samples, MEI was comparable in PT to respective LNM, but significantly different from RD. Up to 25% of patients were negative for pan-MAGE or MAGE-A3/A4 in PT, but positive in RD. The prognostic impact of MAGE expression was validated in the TMA cohort and also in TCGA data (mRNA). OS was significantly lower for patients expressing pan-MAGE or MAGE-A3/A4 in both independent cohorts.MAGE expression was confirmed as a prognostic marker in HNSCC and may be important for immunotherapeutic strategies as a shared antigen.">
<link rel=alternate hreflang=en-us href=https://geertlitjens.nl/publication/laba-17/>
<meta name=theme-color content="hsl(339, 90%, 68%)">
<link rel=stylesheet href=/css/vendor-bundle.min.f1ecf783c14edc00c9320c205831ad8e.css media=print onload="this.media='all'">
<link rel=stylesheet href=https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/styles/vs2015.min.css crossorigin=anonymous title=hl-light media=print onload="this.media='all'">
<link rel=stylesheet href=https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/styles/vs2015.min.css crossorigin=anonymous title=hl-dark media=print onload="this.media='all'" disabled>
<link rel=stylesheet href=/css/wowchemy.7d86dc42c902b14610813b0603567dae.css>
<script async src="https://www.googletagmanager.com/gtag/js?id=UA-139145569-1"></script>
<script>window.dataLayer=window.dataLayer||[];function gtag(){dataLayer.push(arguments)}function trackOutboundLink(a,b){gtag('event','click',{event_category:'outbound',event_label:a,transport_type:'beacon',event_callback:function(){b!=='_blank'&&(document.location=a)}}),console.debug("Outbound link clicked: "+a)}function onClickCallback(a){if(a.target.tagName!=='A'||a.target.host===window.location.host)return;trackOutboundLink(a.target,a.target.getAttribute('target'))}gtag('js',new Date),gtag('config','UA-139145569-1',{}),gtag('set',{cookie_flags:'SameSite=None;Secure'}),document.addEventListener('click',onClickCallback,!1)</script>
<link rel=manifest href=/manifest.webmanifest>
<link rel=icon type=image/png href=/media/icon_hue0c2058e8f722cf54419e3dfd4f45926_15543_32x32_fill_lanczos_center_3.png>
<link rel=apple-touch-icon type=image/png href=/media/icon_hue0c2058e8f722cf54419e3dfd4f45926_15543_180x180_fill_lanczos_center_3.png>
<link rel=canonical href=https://geertlitjens.nl/publication/laba-17/>
<meta property="twitter:card" content="summary">
<meta property="twitter:site" content="@GeertLitjens">
<meta property="twitter:creator" content="@GeertLitjens">
<meta property="og:site_name" content="Geert Litjens">
<meta property="og:url" content="https://geertlitjens.nl/publication/laba-17/">
<meta property="og:title" content="MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences: implications for immunotherapy | Geert Litjens">
<meta property="og:description" content="Melanoma associated antigens (MAGE) are potential targets for immunotherapy and have been associated with poor overall survival (OS) in head and neck squamous cell carcinoma (HNSCC). However, little is known about MAGE in lymph node metastases (LNM) and recurrent disease (RD) of HNSCC.To assess whether MAGE expression increases with metastasis or recurrence, a tissue microarray (TMA) of 552 primary tumors (PT), 219 LNM and 75 RD was evaluated by immunohistochemistry for MAGE antigens using three monoclonal antibodies to multiple MAGE family members. Mean expression intensity (MEI) was obtained from triplicates of each tumor specimen.The median MEI compared between PT, LNM and RD was significantly higher in LNM and RD. In paired samples, MEI was comparable in PT to respective LNM, but significantly different from RD. Up to 25% of patients were negative for pan-MAGE or MAGE-A3/A4 in PT, but positive in RD. The prognostic impact of MAGE expression was validated in the TMA cohort and also in TCGA data (mRNA). OS was significantly lower for patients expressing pan-MAGE or MAGE-A3/A4 in both independent cohorts.MAGE expression was confirmed as a prognostic marker in HNSCC and may be important for immunotherapeutic strategies as a shared antigen."><meta property="og:image" content="https://geertlitjens.nl/media/icon_hue0c2058e8f722cf54419e3dfd4f45926_15543_512x512_fill_lanczos_center_3.png">
<meta property="twitter:image" content="https://geertlitjens.nl/media/icon_hue0c2058e8f722cf54419e3dfd4f45926_15543_512x512_fill_lanczos_center_3.png"><meta property="og:locale" content="en-us">
<meta property="article:published_time" content="2017-01-01T00:00:00+00:00">
<meta property="article:modified_time" content="2017-01-01T00:00:00+00:00">
<script type=application/ld+json>{"@context":"https://schema.org","@type":"Article","mainEntityOfPage":{"@type":"WebPage","@id":"https://geertlitjens.nl/publication/laba-17/"},"headline":"MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences: implications for immunotherapy","datePublished":"2017-01-01T00:00:00Z","dateModified":"2017-01-01T00:00:00Z","author":{"@type":"Person","name":"S. Laban"},"publisher":{"@type":"Organization","name":"Geert Litjens","logo":{"@type":"ImageObject","url":"https://geertlitjens.nl/media/icon_hue0c2058e8f722cf54419e3dfd4f45926_15543_192x192_fill_lanczos_center_3.png"}},"description":"Melanoma associated antigens (MAGE) are potential targets for immunotherapy and have been associated with poor overall survival (OS) in head and neck squamous cell carcinoma (HNSCC). However, little is known about MAGE in lymph node metastases (LNM) and recurrent disease (RD) of HNSCC.To assess whether MAGE expression increases with metastasis or recurrence, a tissue microarray (TMA) of 552 primary tumors (PT), 219 LNM and 75 RD was evaluated by immunohistochemistry for MAGE antigens using three monoclonal antibodies to multiple MAGE family members. Mean expression intensity (MEI) was obtained from triplicates of each tumor specimen.The median MEI compared between PT, LNM and RD was significantly higher in LNM and RD. In paired samples, MEI was comparable in PT to respective LNM, but significantly different from RD. Up to 25% of patients were negative for pan-MAGE or MAGE-A3/A4 in PT, but positive in RD. The prognostic impact of MAGE expression was validated in the TMA cohort and also in TCGA data (mRNA). OS was significantly lower for patients expressing pan-MAGE or MAGE-A3/A4 in both independent cohorts.MAGE expression was confirmed as a prognostic marker in HNSCC and may be important for immunotherapeutic strategies as a shared antigen."}</script>
<title>MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences: implications for immunotherapy | Geert Litjens</title>
</head>
<body id=top data-spy=scroll data-offset=70 data-target=#TableOfContents class="page-wrapper dark" data-wc-page-id=0837322b886e4c88e11f1c4b14b0f17b>
<script src=/js/wowchemy-init.min.b6ac29faab89ee14db88f0bed7aa6622.js></script>
<aside class=search-modal id=search>
<div class=container>
<section class=search-header>
<div class="row no-gutters justify-content-between mb-3">
<div class=col-6>
<h1>Search</h1>
</div>
<div class="col-6 col-search-close">
<a class=js-search href=# aria-label=Close><i class="fas fa-times-circle text-muted" aria-hidden=true></i></a>
</div>
</div>
<div id=search-box>
<input name=q id=search-query placeholder=Search... autocapitalize=off autocomplete=off autocorrect=off spellcheck=false type=search class=form-control aria-label=Search...>
</div>
</section>
<section class=section-search-results>
<div id=search-hits>
</div>
</section>
</div>
</aside>
<div class=page-header>
<header class=header--fixed>
<nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id=navbar-main>
<div class=container-xl>
<div class="d-none d-lg-inline-flex">
<a class=navbar-brand href=/>Geert Litjens</a>
</div>
<button type=button class=navbar-toggler data-toggle=collapse data-target=#navbar-content aria-controls=navbar-content aria-expanded=false aria-label="Toggle navigation">
<span><i class="fas fa-bars"></i></span>
</button>
<div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none">
<a class=navbar-brand href=/>Geert Litjens</a>
</div>
<div class="navbar-collapse main-menu-item collapse justify-content-end" id=navbar-content>
<ul class="navbar-nav d-md-inline-flex">
<li class=nav-item>
<a class=nav-link href=/#posts><span>Posts</span></a>
</li>
<li class=nav-item>
<a class=nav-link href=/#projects><span>Projects</span></a>
</li>
<li class=nav-item>
<a class=nav-link href=/#media><span>Media</span></a>
</li>
<li class=nav-item>
<a class=nav-link href=/#presentations><span>Presentations</span></a>
</li>
<li class=nav-item>
<a class=nav-link href=/#publications><span>Publications</span></a>
</li>
<li class=nav-item>
<a class=nav-link href=/#about><span>About</span></a>
</li>
<li class=nav-item>
<a class=nav-link href=/cv><span>CV</span></a>
</li>
</ul>
</div>
<ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2">
<li class="nav-item dropdown theme-dropdown">
<a href=# class=nav-link data-toggle=dropdown aria-haspopup=true aria-label="Display preferences">
<i class="fas fa-moon" aria-hidden=true></i>
</a>
<div class=dropdown-menu>
<a href=# class="dropdown-item js-set-theme-light">
<span>Light</span>
</a>
<a href=# class="dropdown-item js-set-theme-dark">
<span>Dark</span>
</a>
<a href=# class="dropdown-item js-set-theme-auto">
<span>Automatic</span>
</a>
</div>
</li>
</ul>
</div>
</nav>
</header>
</div>
<div class=page-body>
<div class=pub>
<div class="article-container pt-3">
<h1>MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences: implications for immunotherapy</h1>
<div class=article-metadata>
<div>
<span>
<a href=/authors/s.-laban/>S. Laban</a></span>, <span>
<a href=/authors/g.-giebel/>G. Giebel</a></span>, <span>
<a href=/authors/n.-klumper/>N. Klümper</a></span>, <span>
<a href=/authors/a.-schrk/>A. Schŗ̈k</a></span>, <span>
<a href=/authors/j.-doescher/>J. Doescher</a></span>, <span>
<a href=/authors/g.-spagnoli/>G. Spagnoli</a></span>, <span>
<a href=/authors/j.-thierauf/>J. Thierauf</a></span>, <span>
<a href=/authors/m.-theodoraki/>M. Theodoraki</a></span>, <span>
<a href=/authors/r.-remark/>R. Remark</a></span>, <span>
<a href=/authors/s.-gnjatic/>S. Gnjatic</a></span>, <span>
<a href=/authors/r.-krupar/>R. Krupar</a></span>, <span>
<a href=/authors/a.-sikora/>A. Sikora</a></span>, <span>
<a href=/authors/g.-litjens/>G. Litjens</a></span>, <span>
<a href=/authors/n.-grabe/>N. Grabe</a></span>, <span>
<a href=/authors/g.-kristiansen/>G. Kristiansen</a></span>, <span>
<a href=/authors/f.-bootz/>F. Bootz</a></span>, <span>
<a href=/authors/p.-schuler/>P. Schuler</a></span>, <span>
<a href=/authors/c.-brunner/>C. Brunner</a></span>, <span>
<a href=/authors/j.-brelmann/>J. Br"ëlmann</a></span>, <span>
<a href=/authors/t.-hoffmann/>T. Hoffmann</a></span>, <span>
<a href=/authors/s.-perner/>S. Perner</a></span>
</div>
<span class=article-date>
January, 2017
</span>
</div>
<div class="btn-links mb-3">
<a class="btn btn-outline-primary btn-page-header" href=/publication/laba-17/laba-17.pdf target=_blank rel=noopener>
PDF
</a>
<a class="btn btn-outline-primary btn-page-header" href=/project/aahctd/>
Project
</a>
<a class="btn btn-outline-primary btn-page-header" href=https://doi.org/10.18632/oncotarget.14830 target=_blank rel=noopener>
DOI
</a>
</div>
</div>
<div class=article-container>
<h3>Abstract</h3>
<p class=pub-abstract>Melanoma associated antigens (MAGE) are potential targets for immunotherapy and have been associated with poor overall survival (OS) in head and neck squamous cell carcinoma (HNSCC). However, little is known about MAGE in lymph node metastases (LNM) and recurrent disease (RD) of HNSCC.To assess whether MAGE expression increases with metastasis or recurrence, a tissue microarray (TMA) of 552 primary tumors (PT), 219 LNM and 75 RD was evaluated by immunohistochemistry for MAGE antigens using three monoclonal antibodies to multiple MAGE family members. Mean expression intensity (MEI) was obtained from triplicates of each tumor specimen.The median MEI compared between PT, LNM and RD was significantly higher in LNM and RD. In paired samples, MEI was comparable in PT to respective LNM, but significantly different from RD. Up to 25% of patients were negative for pan-MAGE or MAGE-A3/A4 in PT, but positive in RD. The prognostic impact of MAGE expression was validated in the TMA cohort and also in TCGA data (mRNA). OS was significantly lower for patients expressing pan-MAGE or MAGE-A3/A4 in both independent cohorts.MAGE expression was confirmed as a prognostic marker in HNSCC and may be important for immunotherapeutic strategies as a shared antigen.</p>
<div class=row>
<div class=col-md-1></div>
<div class=col-md-10>
<div class=row>
<div class="col-12 col-md-3 pub-row-heading">Type</div>
<div class="col-12 col-md-9">
<a href=/publication/#3>
Journal article
</a>
</div>
</div>
</div>
<div class=col-md-1></div>
</div>
<div class="d-md-none space-below"></div>
<div class=row>
<div class=col-md-1></div>
<div class=col-md-10>
<div class=row>
<div class="col-12 col-md-3 pub-row-heading">Publication</div>
<div class="col-12 col-md-9"><em>Oncotarget</em></div>
</div>
</div>
<div class=col-md-1></div>
</div>
<div class="d-md-none space-below"></div>
<div class=space-below></div>
<div class=article-style></div>
<div class=article-tags>
<a class="badge badge-light" href=/tag/hnscc-mage-cancer-testis-antigens-head-and-neck-squamous-cell-carcinoma-melanoma-associated-antigen/>HNSCC; MAGE; cancer-testis antigens; head and neck squamous cell carcinoma; melanoma-associated antigen</a>
</div>
<div class=share-box>
<ul class=share>
<li>
<a href="https://twitter.com/intent/tweet?url=https://geertlitjens.nl/publication/laba-17/&text=MAGE%20expression%20in%20head%20and%20neck%20squamous%20cell%20carcinoma%20primary%20tumors,%20lymph%20node%20metastases%20and%20respective%20recurrences:%20implications%20for%20immunotherapy" target=_blank rel=noopener class=share-btn-twitter aria-label=twitter>
<i class="fab fa-twitter"></i>
</a>
</li>
<li>
<a href="https://www.facebook.com/sharer.php?u=https://geertlitjens.nl/publication/laba-17/&t=MAGE%20expression%20in%20head%20and%20neck%20squamous%20cell%20carcinoma%20primary%20tumors,%20lymph%20node%20metastases%20and%20respective%20recurrences:%20implications%20for%20immunotherapy" target=_blank rel=noopener class=share-btn-facebook aria-label=facebook>
<i class="fab fa-facebook"></i>
</a>
</li>
<li>
<a href="mailto:?subject=MAGE%20expression%20in%20head%20and%20neck%20squamous%20cell%20carcinoma%20primary%20tumors,%20lymph%20node%20metastases%20and%20respective%20recurrences:%20implications%20for%20immunotherapy&body=https://geertlitjens.nl/publication/laba-17/" target=_blank rel=noopener class=share-btn-email aria-label=envelope>
<i class="fas fa-envelope"></i>
</a>
</li>
<li>
<a href="https://www.linkedin.com/shareArticle?url=https://geertlitjens.nl/publication/laba-17/&title=MAGE%20expression%20in%20head%20and%20neck%20squamous%20cell%20carcinoma%20primary%20tumors,%20lymph%20node%20metastases%20and%20respective%20recurrences:%20implications%20for%20immunotherapy" target=_blank rel=noopener class=share-btn-linkedin aria-label=linkedin-in>
<i class="fab fa-linkedin-in"></i>
</a>
</li>
<li>
<a href="whatsapp://send?text=MAGE%20expression%20in%20head%20and%20neck%20squamous%20cell%20carcinoma%20primary%20tumors,%20lymph%20node%20metastases%20and%20respective%20recurrences:%20implications%20for%20immunotherapy%20https://geertlitjens.nl/publication/laba-17/" target=_blank rel=noopener class=share-btn-whatsapp aria-label=whatsapp>
<i class="fab fa-whatsapp"></i>
</a>
</li>
<li>
<a href="https://service.weibo.com/share/share.php?url=https://geertlitjens.nl/publication/laba-17/&title=MAGE%20expression%20in%20head%20and%20neck%20squamous%20cell%20carcinoma%20primary%20tumors,%20lymph%20node%20metastases%20and%20respective%20recurrences:%20implications%20for%20immunotherapy" target=_blank rel=noopener class=share-btn-weibo aria-label=weibo>
<i class="fab fa-weibo"></i>
</a>
</li>
</ul>
</div>
</div>
</div>
</div>
<div class=page-footer>
<div class=container>
<footer class=site-footer>
<p class=powered-by>
© 2019
</p>
<p class=powered-by>
Published with <a href="https://wowchemy.com/?utm_campaign=poweredby" target=_blank rel=noopener>Wowchemy</a> — the free, <a href=https://github.com/wowchemy/wowchemy-hugo-themes target=_blank rel=noopener>open source</a> website builder that empowers creators.
</p>
</footer>
</div>
</div>
<div id=modal class="modal fade" role=dialog>
<div class=modal-dialog>
<div class=modal-content>
<div class=modal-header>
<h5 class=modal-title>Cite</h5>
<button type=button class=close data-dismiss=modal aria-label=Close>
<span aria-hidden=true>&#215;</span>
</button>
</div>
<div class=modal-body>
<pre><code class="tex hljs"></code></pre>
</div>
<div class=modal-footer>
<a class="btn btn-outline-primary my-1 js-copy-cite" href=# target=_blank>
<i class="fas fa-copy"></i> Copy
</a>
<a class="btn btn-outline-primary my-1 js-download-cite" href=# target=_blank>
<i class="fas fa-download"></i> Download
</a>
<div id=modal-error></div>
</div>
</div>
</div>
</div>
<script src=/js/vendor-bundle.min.b73dfaac3b6499dc997741748a7c3fe2.js></script>
<script src=https://cdn.jsdelivr.net/gh/desandro/imagesloaded@v4.1.4/imagesloaded.pkgd.min.js integrity="sha512-S5PZ9GxJZO16tT9r3WJp/Safn31eu8uWrzglMahDT4dsmgqWonRY9grk3j+3tfuPr9WJNsfooOR7Gi7HL5W2jw==" crossorigin=anonymous></script>
<script src=https://cdn.jsdelivr.net/gh/metafizzy/isotope@v3.0.6/dist/isotope.pkgd.min.js integrity="sha512-Zq2BOxyhvnRFXu0+WE6ojpZLOU2jdnqbrM1hmVdGzyeCa1DgM3X5Q4A/Is9xA1IkbUeDd7755dNNI/PzSf2Pew==" crossorigin=anonymous></script>
<script src=https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/highlight.min.js integrity="sha512-Ypjm0o7jOxAd4hpdoppSEN0TQOC19UtPAqD+4s5AlXmUvbmmS/YMxYqAqarQYyxTnB6/rqip9qcxlNB/3U9Wdg==" crossorigin=anonymous></script>
<script src=https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/languages/python.min.js crossorigin=anonymous></script>
<script src=https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/languages/bash.min.js crossorigin=anonymous></script>
<script id=search-hit-fuse-template type=text/x-template>
        <div class="search-hit" id="summary-{{key}}">
          <div class="search-hit-content">
            <div class="search-hit-name">
              <a href="{{relpermalink}}">{{title}}</a>
              <div class="article-metadata search-hit-type">{{type}}</div>
              <p class="search-hit-description">{{snippet}}</p>
            </div>
          </div>
        </div>
      </script>
<script src=https://cdn.jsdelivr.net/gh/krisk/Fuse@v3.2.1/dist/fuse.min.js integrity="sha512-o38bmzBGX+hD3JHWUFCDA09btWaqrNmoJ3RXLlrysA7PP01Kgs4UlE4MhelE1v5dJR3+cxlR4qQlotsW7jKsnw==" crossorigin=anonymous></script>
<script src=https://cdn.jsdelivr.net/gh/julmot/mark.js@8.11.1/dist/jquery.mark.min.js integrity="sha512-mhbv5DqBMgrWL+32MmsDOt/OAvqr/cHimk6B8y/bx/xS88MVkYGPiVv2ixKVrkywF2qHplNRUvFsAHUdxZ3Krg==" crossorigin=anonymous></script>
<script id=page-data type=application/json>{"use_headroom":true}</script>
<script src=/js/wowchemy-headroom.1cb9e2fc8399acee94eab837265b73bf.js type=module></script>
<script src=/en/js/wowchemy.min.0cb61b39a43590bf7470ddb0caa9f812.js></script>
</body>
</html>